Trial Profile
A retrospective, pilot study to evaluate the feasibility of ferumoxytol as an off-label contrast agent in body 3T MR angiography in children
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Apr 2016
Price :
$35
*
At a glance
- Drugs Ferumoxytol (Primary)
- Indications Iron deficiency anaemia; Peripheral arterial disorders
- Focus Diagnostic use
- 28 Apr 2016 New trial record